Company Performance - Doximity (DOCS) closed at $43.53, down 3.22% from the previous day's closing price, underperforming the S&P 500 which gained 0.46% [1] - The stock has decreased by 9.95% over the past month, while the Medical sector gained 1.59% and the S&P 500 increased by 4.22% [1] Upcoming Financial Results - Doximity is expected to report an EPS of $0.44, a decrease of 2.22% compared to the same quarter last year [2] - Revenue is projected to be $181.03 million, reflecting a 7.37% increase from the equivalent quarter last year [2] Fiscal Year Projections - For the entire fiscal year, earnings are projected at $1.56 per share, representing a 9.86% increase from the prior year [3] - Revenue for the fiscal year is estimated at $645.29 million, indicating a 13.13% increase from the previous year [3] Analyst Estimates and Revisions - Recent modifications to analyst estimates for Doximity indicate short-term business trends, with upward revisions suggesting positive sentiment towards the company's operations [4] - The Zacks Rank system, which incorporates these estimate changes, currently ranks Doximity at 3 (Hold) [6] Valuation Metrics - Doximity has a Forward P/E ratio of 28.75, which is a discount compared to the industry average Forward P/E of 46.25 [6] - The company has a PEG ratio of 1.52, significantly lower than the Medical Info Systems industry's average PEG ratio of 3.49 [7] Industry Context - The Medical Info Systems industry, part of the Medical sector, holds a Zacks Industry Rank of 102, placing it in the top 42% of over 250 industries [7] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [8]
Doximity (DOCS) Stock Falls Amid Market Uptick: What Investors Need to Know